Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation

AIMS: The global COVID-19 pandemic is caused by the SARS-CoV-2 virus entering human cells using angiotensin-converting enzyme 2 (ACE2) as a cell surface receptor. ACE2 is shed to the circulation, and a higher plasma level of soluble ACE2 (sACE2) might reflect a higher cellular expression of ACE2. Th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Heart J
Autors principals: Wallentin, Lars, Lindbäck, Johan, Eriksson, Niclas, Hijazi, Ziad, Eikelboom, John W, Ezekowitz, Michael D, Granger, Christopher B, Lopes, Renato D, Yusuf, Salim, Oldgren, Jonas, Siegbahn, Agneta
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7543499/
https://ncbi.nlm.nih.gov/pubmed/32984892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehaa697
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars